When facing the challenge of improving total shareholder return (TSR), most executives default to growth. But as much as ...
If coworkers cranking out biz strategies and fussing over balance sheets seem robotic, you ain't seen nothing yet ...
Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.
Intrepid Potash benefits from being the sole domestic potash producer in the U.S. Read why I maintain my buy rating on IPI ...
Genome BC has helped secure more than $49 million for research to be conducted in British Columbia by five projects using genomics to advance personalized healthcare. Three of these projects are led ...
Bitcoin has followed a pattern of four-year cycles. These cycles, tied to Bitcoin’s unique halving mechanism, have been ...
We recently compiled a list of the 10 Best Debt Free Mid Cap Stocks to Buy Now. In this article, we are going to take a look ...
We recently published a list of 12 Best Consistent Dividend Stocks to Buy. In this article, we are going to take a look at ...
For Volvo, the EX90 couldn’t be a more important vehicle, and that’s despite the segment it’s entering being one of the ...
The Credit Ratings (ratings) reflect BGRe’s balance sheet strength, which AM Best assesses as strongest, as well as its adequate operating performance, neutral business profile and appropriate ...
The ratings reflect Pie’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, limited business profile and appropriate enterprise risk ...
Revenue grew approximately 270% to $9.4 million in 2024, a significant increase from $2.5 million in 2023. Increased Demand: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results